Inozyme Pharmainc Stock Technical Analysis
| INZY Stock | USD 4.40 0.01 0.23% |
As of the 24th of April, Inozyme PharmaInc retains the Risk Adjusted Performance of 0.0314, downside deviation of 4.54, and Market Risk Adjusted Performance of 0.0665. Inozyme PharmaInc technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Inozyme PharmaInc, which can be compared to its competitors. Please check out Inozyme PharmaInc value at risk, and the relationship between the jensen alpha and semi variance to decide if Inozyme PharmaInc is priced fairly, providing market reflects its last-minute price of 4.4 per share. Given that Inozyme PharmaInc has jensen alpha of (0.07), we strongly advise you to confirm Inozyme PharmaInc's regular market performance to make sure the company can sustain itself at a future point.
Inozyme PharmaInc Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Inozyme, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InozymeInozyme |
Inozyme PharmaInc Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 21.0 | Strong Buy | 7 | Odds |
Most Inozyme analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inozyme stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inozyme PharmaInc, talking to its executives and customers, or listening to Inozyme conference calls.
Inozyme PharmaInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Inozyme PharmaInc Technical Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Inozyme PharmaInc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Inozyme PharmaInc Trend Analysis
Use this graph to draw trend lines for Inozyme PharmaInc. You can use it to identify possible trend reversals for Inozyme PharmaInc as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Inozyme PharmaInc price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Inozyme PharmaInc Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Inozyme PharmaInc applied against its price change over selected period. The best fit line has a slop of 0.002 , which may suggest that Inozyme PharmaInc market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.15, which is the sum of squared deviations for the predicted Inozyme PharmaInc price change compared to its average price change.About Inozyme PharmaInc Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Inozyme PharmaInc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Inozyme PharmaInc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Inozyme PharmaInc price pattern first instead of the macroeconomic environment surrounding Inozyme PharmaInc. By analyzing Inozyme PharmaInc's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Inozyme PharmaInc's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Inozyme PharmaInc specific price patterns or momentum indicators. Please read more on our technical analysis page.
Inozyme PharmaInc April 24, 2024 Technical Indicators
Most technical analysis of Inozyme help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Inozyme from various momentum indicators to cycle indicators. When you analyze Inozyme charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0314 | |||
| Market Risk Adjusted Performance | 0.0665 | |||
| Mean Deviation | 3.77 | |||
| Semi Deviation | 4.45 | |||
| Downside Deviation | 4.54 | |||
| Coefficient Of Variation | 2714.22 | |||
| Standard Deviation | 4.91 | |||
| Variance | 24.13 | |||
| Information Ratio | 0.0187 | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.46) | |||
| Sortino Ratio | 0.0202 | |||
| Treynor Ratio | 0.0565 | |||
| Maximum Drawdown | 25.32 | |||
| Value At Risk | (8.42) | |||
| Potential Upside | 8.83 | |||
| Downside Variance | 20.58 | |||
| Semi Variance | 19.78 | |||
| Expected Short fall | (4.20) | |||
| Skewness | 0.4041 | |||
| Kurtosis | 0.9036 |
Inozyme PharmaInc April 24, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Inozyme stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 35,360 | ||
| Daily Balance Of Power | 0.05 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 4.51 | ||
| Day Typical Price | 4.47 | ||
| Price Action Indicator | (0.10) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inozyme PharmaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Inozyme Stock please use our How to Invest in Inozyme PharmaInc guide.Note that the Inozyme PharmaInc information on this page should be used as a complementary analysis to other Inozyme PharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Inozyme Stock analysis
When running Inozyme PharmaInc's price analysis, check to measure Inozyme PharmaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inozyme PharmaInc is operating at the current time. Most of Inozyme PharmaInc's value examination focuses on studying past and present price action to predict the probability of Inozyme PharmaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inozyme PharmaInc's price. Additionally, you may evaluate how the addition of Inozyme PharmaInc to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Inozyme PharmaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inozyme PharmaInc. If investors know Inozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inozyme PharmaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.37) | Return On Assets (0.28) | Return On Equity (0.55) |
The market value of Inozyme PharmaInc is measured differently than its book value, which is the value of Inozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Inozyme PharmaInc's value that differs from its market value or its book value, called intrinsic value, which is Inozyme PharmaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inozyme PharmaInc's market value can be influenced by many factors that don't directly affect Inozyme PharmaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inozyme PharmaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inozyme PharmaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inozyme PharmaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.